Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome

Human Pathology

Volumn 40, Issue 11, 2009, Pages 1618-1627

  Kang, Dedong ^a   Nakayama, Tomoko ^a   Togashi, Mayuko ^a   Yamamoto, Masuki ^a   Takahashi, Mikiko ^a   Kunugi, Shinobu ^a   Ishizaki, Masamichi ^a   Fukuda, Yuh ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Diffuse alveolar damage; Multiple organ dysfunction Syndrome; Myofibroblast

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 1; KI 67 ANTIGEN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; AUTOPSY; CANCER CHEMOTHERAPY; CELL DAMAGE; CELL PROLIFERATION; CLINICAL ARTICLE; DIFFUSE ALVEOLAR DAMAGE; FEMALE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG INJURY; MALE; MULTIPLE ORGAN FAILURE; MYOFIBROBLAST; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFECTION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 70349849388     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.04.019     Document Type: Article

References (29)

1. Hudson L.D., Milberg J.A., Anardi D., and Maunder R.J. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151 (1995) 293-301
2. Doyle R.L., Szaflarski N., Modin G.W., Wiener-Kronish J.P., and Matthay M.A. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 152 (1995) 1818-1824
3. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl Med 342 (2000) 1334-1349
4. Tomashefski Jr. J.F., Davies P., Boggis C., Greene R., et al. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 112 (1983) 112-126
5. Moloney E.D., and Evans T.W. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J 21 (2003) 720-727
6. Khadaroo R.G., and Marshall J.C. ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process. Crit Care Clin 18 (2002) 127-141
7. Madhav B., and Shabbir M. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202 (2004) 145-156
8. Katzenstein A.A., and Jeffrey L.M. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Crit Care Med 157 (1998) 1301-1315
9. Larson D.L., Abston S., Wills B., et al. Contracture and scar formation in the burn patient. Clin Plast Surg 1 (1974) 653-656
10. Schurch W., Seemayer T.A., Hinz B., and Gabbiani G. Myofibroblast. In: Mills S.E. (Ed). Histology for pathologists (2007), Lippincott Williams and Wilkins, Philadelphia, USA 123-156
11. Virag J.I., and Murry C.E. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 163 (2003) 6124-6134
12. Nagle R.B., Kneiser M.R., Bulger R.E., and Benditt E.P. Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 29 (1973) 422-427
13. Guyot C., Lepreux S., Combe C., et al. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 38 (2006) 135-151
14. Hao H., Gabbiani G., Camenzind E., et al. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Bio 26 (2006) 326-332
15. Zalewski A., Shi Y., and Johnson A.G. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?. Circ Res 91 (2002) 652-655
16. Fukuda Y., Ishizaki M., Masuda Y., et al. The role of intraalveolar fibrosis in the process of pulmonary structure remodeling in patients with diffuse alveolar damage. AM J Pathol 126 (1987) 171-182
17. Zhang K., Rekhter M.D., Gordon D., and Phan S.H. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 145 (1994) 114-125
18. Gabbrielli S., Di Lollo S., Stanflin N., and Romagnoli P. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma. Pathologica 86 (1994) 157-160
19. Schurch W., Seemayer T., Lagace R., and Gabbiani G. The intermediate filament cytoskeleton of myofibroblasts. Virchows Arch A 403 (1984) 323-336
20. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., and Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12 (2001) 2730-2741
21. Fukuda Y., Basset F., Ferrans V.J., and Yamanaka N. Significance of early intraalveolar fibrotic lesions and integrin expression in lung biopsies from patients with idiopathic pulmonary fibrosis. Hum Pathol l26 (1995) 53-61
22. Vyalov S.L., Gabbiani G., and Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 143 (1993) 1754-1765
23. Zhang H.Y., Gharaee-Kermani M., Zhang K., Karmiol S., and Phan S.H. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 148 (1996) 527-537
24. Maniatis N.A., and Orfanos S.E. The endothelium in acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 14 (2008) 22-30
25. Katzenstein A.A. Idiopathic interstitial pneumonia. In: Katzenstein A.A. (Ed). Surgical pathology of non-neoplastic lung disease (2006), Elsevier Inc., Philadelphia, USA 66-67
26. Fukuda Y., Ferrans V.J., Schoenberger C.I., Rennard S.I., and Crystal R.G. Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am J Pathol 118 (1985) 452-475
27. Dimopoulou I., Bamias A., Lyberopoulos P., and Dimopoulos M.A. Pulmonary toxicity from novel antineoplastic agents. Ann Oncol 17 (2006) 372-379
28. Moore B.B., and Hogaboam C.M. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 294 (2008) L152-L160
29. Limper A.H., and Rosenow E.C. Drug-induced pulmonary disease. In: Murray J., and et a. (Eds). Textbook of respiratory medicine (2000), Saunders Press, Philadelphia, USA 1971-1994